1. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
2. Institute of Hematology, University of Perugia, Perugia, Italy;
3. Institute of Cancer, Barts and the London School of Medicine, London, United Kingdom;
4. Karlsruhe Institute of Technology, Forschungszentrum Karlsruhe, Karlsruhe, Germany; and
5. Division of Hematology/Oncology, Department of Pediatrics, Children's Hospital, Harvard Medical School, Boston, MA